However, OX40 is a very specialized marker expressed primarily by recently activated CD4+ T lymphocytes showing preferential accumulation at tumor sites in cancer patients and is thought to represent tumor antigen specific T cells [26,27]. This evidence concerns the gene CD4 and neoplasm.